| Intrinsic Valuation of: ZYDUSLIFE | |||||||||||
| Free Cash Flow Average and Growth over past 5Y | Key Statistics | ||||||||||
| Year | FCF | FCF (FCF/Revenue) | |||||||||
| 2020 | - | - | EPS (FY) | 45 | Market Cap | ₹1,009B | |||||
| 2021 | - | - (-) | P/E Ratio | 22 | Total Asset | ₹372B | |||||
| 2022 | ₹9B | - (-) | Net Income | ₹45B | Total Debt | ₹0 | |||||
| 2023 | ₹17B | 83.8% (61.5%) | EBITDA | ₹71B | Total Liab | ₹108B | |||||
| 2024 | ₹23B | 38.1% (22.5%) | Opr Margin | 0.26 | Debt/Equity | - | |||||
| 2025 | ₹51B | 121.2% (86.4%) | PreTax Margin | 25.75 | BV/Share | 154 | |||||
| 5Y Average FCF | ₹25B | 81.0% (56.8%) | |||||||||
| Overall Market Assumptions: | |||||||||||
| Assumptions: | P/E for No-Growth Company: | 7.0 | |||||||||
| Perpetual Growth Rate (g): | 2.5% | Historical US Bond Yield: | 4.4% | ||||||||
| Discount Rate (WACC): | 7.4% | Current US Bond Yield: | 3.5% | ||||||||
| Forcasting Future Free Cash Flow for next 6Y | Modified Benjamin Graham's Intrinsic Value | ||||||||||
| Year | FCF Projection (25.0%) | ||||||||||
| 2026 | ₹63B | MBG Intrinsic Value | ₹403 | ||||||||
| 2027 | ₹79B | ||||||||||
| 2028 | ₹99B | ||||||||||
| 2029 | ₹124B | ||||||||||
| 2030 | ₹155B | ||||||||||
| 2031 | ₹193B | ||||||||||
| Terminal Value | ₹4,016B | Net Worth/Share | ₹262 | ||||||||
| DCF Valuation | DCF Valuation "What If" Scenario Table | ||||||||||
| Enterprise Value | ₹3,146B | Growth Rate | |||||||||
| (+) Cash & Cash Equivalents | ₹8B | ₹3,135 | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% | ||||
| (-) Total Debt | ₹0 | WACC | 7.3% | 2,727 | 2,944 | 3,206 | 3,528 | 3,934 | |||
| Equity Value | ₹3,155B | 7.4% | 2,701 | 2,914 | 3,170 | 3,485 | 3,880 | ||||
| Shares Outstanding | 1,006,230,016 | 7.4% | 2,676 | 2,885 | 3,135 | 3,442 | 3,828 | ||||
| 7.9% | 2,446 | 2,618 | 2,822 | 3,067 | 3,367 | ||||||
| DCF Intrinsic Value | ₹3,135 | 8.4% | 2,250 | 2,394 | 2,562 | 2,761 | 3,000 | ||||
| Analyzed by QuantJuice (2025) | |||||||||||